In malignant tumors such as breast carcinomas, endometrial carcinomas, and colorectal cancers, PD-L1 expression was increased in cases of microsatellite instability showing MMR protein deficiency or abnormality of MMR mechanism [29,30,31]. Here, MRC1 is linked to breast carcinoma.